首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Esmo open

缩写:

ISSN:N/A

e-ISSN:2059-7029

IF/分区:8.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2013
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
M Wakabayashi,H Taniguchi,A Makiyama et al. M Wakabayashi et al.
Background: Trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) remains a standard of care for refractory metastatic colorectal cancer (mCRC), though hematological toxicities remain a concern. Although a biweekly regi...
A Strahan,Q Jin,A S Raghavendra et al. A Strahan et al.
Background: For patients diagnosed with triple-negative breast cancer (TNBC), residual disease (RD) after neoadjuvant chemotherapy (NAC) is associated with increased rates of recurrence and poor prognosis. Adjuvant therap...
A Fritzsch,K Leucht,N Röber et al. A Fritzsch et al.
Background: Immune checkpoint inhibitor (ICI) administration profoundly promotes T-cell-mediated antitumor effects, but also frequently causes the development of immune-related adverse events (irAEs) in cancer patients. P...
H R Howard,M Hasanova,A Tiwari et al. H R Howard et al.
Globally, lung cancer remains the most common cause of cancer mortality, with non-small-cell lung cancer (NSCLC) being the most common subtype of lung cancer diagnosed. This review paper provides a comprehensive landscape of clinical predic...
Y-W Zhou,G-X Wei,X-R Chen et al. Y-W Zhou et al.
Background: To evaluate the safety and deliverability of neoadjuvant chemotherapy (NAC) with three-drug-intensity chemotherapy [oxaliplatin, irinotecan, and fluorouracil (FOLFOXIRI)] in patients with high-risk factors for...
E Finn,S Sardo Infirri,C S Clarke et al. E Finn et al.
Background: Li Fraumeni syndrome (LFS), a rare genetic condition, poses a significant health impact due to the ∼75%-90% lifetime risk of developing cancer in affected individuals. Due to the rarity of this disease, littl...
A R Filippi,M R García Campelo,J-B Paoli et al. A R Filippi et al.
Background: Currently, patients with unresectable stage III non-small-cell lung cancer (NSCLC) ineligible for chemotherapy receive radiotherapy alone, with unsatisfactory results. DUART was a phase II single-arm trial of ...
D S T Cheung,W F Yeung,P H Chau et al. D S T Cheung et al.
Background: Acupressure and qigong are Chinese medicine-based modalities that can work in synergy to improve chemotherapy-induced peripheral neuropathy (CIPN). This study examines the effect of a combined qigong and acupr...